Novo Nordisk’s takeover of Catalent and the Danish firm’s push to launch a new generation of drugs could boost the importance of GLP agonists in 2025, Barclays analysts said
Source link
Check Also
Wall Street’s Santa Claus rally window is about to open with the Dow down in December
Stocks have struggled ahead of the holidays despite Friday’s rally. Source link